Comment on

• Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society.

  Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, Bucsky P, Egeler RM, Elinder G, Gadner H, Gresik M, Henter JI, Imashuku S, Janka-Schaub G, Jaffe R, Ladisch S, Nezelof C, Pritchard J. Favara BE, et al. Med Pediatr Oncol. 1997 Sep;29(3):157-66. doi: 10.1002/(sici)1096-911x(199709)29:3<157::aid-mpo1>3.0.co;2-c. Med Pediatr Oncol. 1997. PMID: 9212839 Review.
• Concurrent Langerhans cell histiocytosis and myelodysplasia in children.

  Surico G, Muggeo P, Rigillo N, Gadner H. Surico G, et al. Med Pediatr Oncol. 2000 Oct;35(4):421-5. doi: 10.1002/1096-911x(20001001)35:4<421::aid-mpo5>3.0.co;2-h. Med Pediatr Oncol. 2000. PMID: 11025473
• Is Langerhans cell histiocytosis a myeloid dendritic stem cell disorder related to myelodysplastic disorders?

  Egeler RM, Willman CL. Egeler RM, et al. Med Pediatr Oncol. 2000 Oct;35(4):426-7. doi: 10.1002/1096-911x(20001001)35:4<426::aid-mpo6>3.0.co;2-#. Med Pediatr Oncol. 2000. PMID: 11025474 No abstract available.
• Langerhans cell histiocytosis: a reactive or neoplastic disorder?

  Zelger B. Zelger B. Med Pediatr Oncol. 2001 Dec;37(6):543-4. doi: 10.1002/mpo.1249. Med Pediatr Oncol. 2001. PMID: 11745894 No abstract available.